Dengvaxia®: Prayers Answered or NOT?

Published

2016-12-31

Dimensions Badge

Issue

Section

Perspective

Authors

  • Deepak Gupta

Abstract

Dengvaxia is the first vaccine against dengue that has been developed after decades of toiling to tame the four-strain dengue virus. The questions have already been raised regarding its non-utility for the younger ones and the seronegative population due to ethical concern of non-maleficence (do-no-harm). It is not clear where this leaves the endemic populations suffering for decades from un-resolving morbidity and mortality burdens of dengue fever, and whether this worsens the dilemma of those populations’ rattled-governments planning to ride the approaching bandwagons of mass vaccination programs against dengue. Irrespective, people and personnel living in dengue-endemic regions should welcome hands down this human endeavour to develop Dengvaxia, the first vaccine against dengue.  

How to Cite

1.
Gupta D. Dengvaxia®: Prayers Answered or NOT?. Indian J Community Health [Internet]. 2016 Dec. 31 [cited 2022 Oct. 4];28(4):398-9. Available from: https://www.iapsmupuk.org/journal/index.php/IJCH/article/view/711

Downloads

Download data is not yet available.

Most read articles by the same author(s)

1 2 > >>